Compare · LFST vs TOI
LFST vs TOI
Side-by-side comparison of LifeStance Health Group Inc. (LFST) and The Oncology Institute Inc. (TOI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LFST and TOI operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- LFST is the larger of the two at $4.49B, about 8.4x TOI ($534.9M).
- Over the past year, LFST is up 173.8% and TOI is up 53.0% - LFST leads by 120.8 points.
- LFST has been more active in the news (13 items in the past 4 weeks vs 8 for TOI).
- LFST has more recent analyst coverage (17 ratings vs 8 for TOI).
- Company
- LifeStance Health Group Inc.
- The Oncology Institute Inc.
- Price
- $11.57+2.39%
- $5.36+1.81%
- Market cap
- $4.49B
- $534.9M
- 1M return
- +34.07%
- +4.79%
- 1Y return
- +173.85%
- +53.00%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2020
- News (4w)
- 13
- 8
- Recent ratings
- 17
- 8
LifeStance Health Group Inc.
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. The company offers patients care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was incorporated in 2021 and is based in Scottsdale, Arizona.
The Oncology Institute Inc.
The Oncology Institute, Inc. provides cancer awareness, prevention, diagnosis, treatment, and education service. The company offers chemotherapy education, comprehensive lab testing, pain management, financial counseling, end of life counseling, dietary counseling, in-house infusion center, in-house support groups, in-house pharmacy, nutraceuticals, clinical trials, and educational seminars. It also operates the hope, health, and healing center to offer patients alternative and holistic treatments in addition to chemotherapy. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Latest LFST
- LifeStance to Host Second Quarter 2026 Earnings Conference Call on August 6, 2026
- Director Burdick Kenneth A was granted 45,495 shares, increasing direct ownership by 1% to 3,470,810 units (SEC Form 4)
- Director Palmer Eric P was granted 17,746 shares, increasing direct ownership by 25% to 89,174 units (SEC Form 4)
- Director Bessler Robert was granted 17,746 shares, increasing direct ownership by 31% to 75,365 units (SEC Form 4)
- Director Personette Sarah was granted 17,746 shares, increasing direct ownership by 24% to 92,512 units (SEC Form 4)
- Director Deluca Teresa was granted 17,746 shares, increasing direct ownership by 17% to 125,034 units (SEC Form 4)
- Director Justice Thurman was granted 35,492 shares (SEC Form 4)
- Director Goltermann Lori was granted 35,492 shares (SEC Form 4)
- SEC Form 3 filed by new insider Goltermann Lori
- SEC Form 3 filed by new insider Justice Thurman
Latest TOI
- Chief Medical Officer Podnos Yale exercised 23,452 shares at a strike of $1.90 and sold $150,340 worth of shares (23,452 units at $6.41) (SEC Form 4)
- Large owner Chernett Jorey bought $87,750 worth of shares (15,000 units at $5.85), increasing direct ownership by 0.14% to 10,630,858 units (SEC Form 4)
- Director Tzoumakas Kimberly Jo was granted 17,185 shares (SEC Form 4)
- Director Stolper Mark was granted 25,833 shares (SEC Form 4)
- The Oncology Institute Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
- The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity
- Lake Street initiated coverage on The Oncology Institute with a new price target
- Large owner Chernett Jorey bought $90,360 worth of shares (18,000 units at $5.02), increasing direct ownership by 0.17% to 10,615,858 units (SEC Form 4)
- The Oncology Institute Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Chief Medical Officer Podnos Yale sold $126,094 worth of shares (23,451 units at $5.38) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 259,527 units (SEC Form 4)